PhII ICb With/Without Erbitux in MBC Pts

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by US Oncology Research.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Bristol-Myers Squibb
Pfizer
Information provided by:
US Oncology Research
ClinicalTrials.gov Identifier:
NCT00248287
First received: November 2, 2005
Last updated: June 8, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)